Literature DB >> 3763366

Inclusion complexation of warfarin with cyclodextrins to improve some pharmaceutical characteristics.

S Y Lin, J C Yang.   

Abstract

Inclusion complexation of warfarin and alpha- or beta-cyclodextrins in water and in the solid phase were studied by a solubility method, a membrane permeation study, thin-layer chromatography, a dissolution study, IR spectroscopy and differential scanning calorimetry. The solubility of warfarin increased with the addition of cyclodextrins. The apparent stability constants of the alpha- and beta-cyclodextrin complexes are 10.29 M-1 and 148.88 M-1, respectively. The greater the stability constant of the inclusion complex the lesser the permeability of warfarin. Solid complexes of warfarin and alpha- or beta-cyclodextrins were obtained by freeze-drying. Clear differences in IR absorption spectra and DSC thermograms were observed between the inclusion complexes and physical mixtures. The dissolution rate of the freeze-dried warfarin-cyclodextrin complexes was increased about 1200-fold and 550-fold for alpha- and beta-cyclodextrins, respectively. The dissolution rate of warfarin was significantly improved by complex formation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3763366     DOI: 10.1007/bf01957782

Source DB:  PubMed          Journal:  Pharm Weekbl Sci        ISSN: 0167-6555


  11 in total

1.  The effect of charges on permeabilities of drugs through collagen membranes.

Authors:  M Nakano; A Kuchiki; T Arita
Journal:  Chem Pharm Bull (Tokyo)       Date:  1976-10       Impact factor: 1.645

2.  Effect of coadministration of aluminum and magnesium hydroxides on absorption of anticoagulants in man.

Authors:  J J Ambre; L J Fischer
Journal:  Clin Pharmacol Ther       Date:  1973 Mar-Apr       Impact factor: 6.875

3.  Bioavailability of dicumarol from different commercial tablets in dogs.

Authors:  M J Akers; J L Lach; L J Fischer
Journal:  J Pharm Sci       Date:  1973-07       Impact factor: 3.534

4.  In vivo and in vitro availability of commercial warfarin tablets.

Authors:  J G Wagner; P G Welling; K P Lee; J E Walker
Journal:  J Pharm Sci       Date:  1971-05       Impact factor: 3.534

5.  Biopharmaceutical study of inclusion complexes. I. Pharmaceutical advantages of cyclodextrin complexes of bencyclane fumarate.

Authors:  K Fujioka; Y Kurosaki; S Sato; T Noguchi; T Noguchi; Y Yamahira
Journal:  Chem Pharm Bull (Tokyo)       Date:  1983-07       Impact factor: 1.645

6.  Improvements to some pharmaceutical properties of flurbiprofen by beta- and gamma-cyclodextrin complexations.

Authors:  M Otagiri; T Imai; N Matsuo; K Uekama
Journal:  Acta Pharm Suec       Date:  1983

Review 7.  [Pharmaceutical applications of cyclodextrin complexations (author's transl)].

Authors:  K Uekama
Journal:  Yakugaku Zasshi       Date:  1981-10       Impact factor: 0.302

8.  Stoichiometric model of alpha-cyclodextrin complex formation.

Authors:  T W Rosanske; K A Connors
Journal:  J Pharm Sci       Date:  1980-05       Impact factor: 3.534

9.  Structure of warfarin in solution.

Authors:  E J Valente; E C Lingafelter; W R Porter; W F Trager
Journal:  J Med Chem       Date:  1977-11       Impact factor: 7.446

10.  Interaction between warfarin and nonsteroidal anti-inflammatory drugs (NSAIDs) in rats.

Authors:  L F Sancilio; M A Taylor; P P Mathur; J T Crowe
Journal:  Life Sci       Date:  1985-03-18       Impact factor: 5.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.